Longer IFN Therapy in HCV Infection Is Beneficial. Part 1
April 11th, 2012
Comments Off
Several studies reaffirmed the benefits of longer-term IFN therapy on sustained response rates and liver histology.
Bellobuono and colleagues (Milan, Italy) compared six and twelve months of IFN alfa-2b therapy in men with an unknown serum HCV RNA after one month of treatment. One hundred thirty patients with biopsy-proven chronic hepatitis C without cirrhosis received IFN alfa-2b 5-8 MU TIW (genotype 1 a or 1b) or 3-5 MU TIW (genotype 2a or 3a) for 1 month. Read more…